Tempus AI is positioned for success with its innovative technology and strategic partnerships, making it a strong potential investment in the healthcare industry.
Bears say
Tempus AI is a technology company focused on precision medicine through the application of AI in healthcare. Despite having one of the largest libraries of clinical and molecular data and potential opportunities for growth through the recent acquisition of Personalis, Tempus operates in a highly competitive landscape and faces risks from established players and emerging startups. Additionally, the company has incurred significant losses since inception, has debt on its balance sheet, and may not be able to generate enough revenue to achieve profitability.
TEM has been analyzed by 14 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 21% recommend Buy, 29% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.
This aggregate rating is based on analysts' research of Tempus AI Inc and is not a guaranteed prediction by Public.com or investment advice.
TEM Analyst Forecast & Price Prediction
Get the latest TEM stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Analysts have given TEM a Buy based on their latest research and market trends.
According to 14 analysts, TEM has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $64.50, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $64.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.
Tempus AI Inc (TEM)
TEM Analyst Forecast & Price Prediction
Get the latest TEM stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.